These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11939489)

  • 1. Experience with external quality assessment of drugs of abuse testing in the Lombardy Region in Italy.
    Cassani M; Giuliani L; Amigoni M; Buratta A; Marocchi A
    Clin Chem Lab Med; 2002 Feb; 40(2):156-64. PubMed ID: 11939489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four years' experience in external proficiency testing programs for hair testing of drugs of abuse in Italy (HAIRVEQ) and comparison with the Society of Hair Testing program in 2005.
    Ventura M; Pichini S; Pujadas M; Ventura R; Di Giovannandrea R; Zuccaro P; Pacifici R; Langohr K; Jurado C; de la Torre R
    Ther Drug Monit; 2007 Feb; 29(1):11-9. PubMed ID: 17304145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical and health governance aspects of the external quality assessment system for classical and new psychoactive substances analysis testing in blood.
    Di Gaudio F; Giaccone V; Cucina A; Indelicato S; Raso M; Brunacci G; Lundari A; Rotolo MC; Busardò F; La Rocca M
    J Pharm Biomed Anal; 2024 Aug; 245():116175. PubMed ID: 38728951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proficiency testing for psychoactive substances in Italy.
    Ferrara SD; Brusini G; Maietti S; Frison G; Castagna F; Allevi S; Menegus AM; Tedeschi L
    Int J Legal Med; 1999; 113(1):50-4. PubMed ID: 10654240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The standardization of results on hair testing for drugs of abuse: An interlaboratory exercise in Lombardy Region, Italy.
    Stramesi C; Vignali C; Groppi A; Caligara M; Lodi F; Pichini S; Jurado C
    Forensic Sci Int; 2012 May; 218(1-3):101-5. PubMed ID: 22018743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of drugs of abuse testing by clinical laboratories in the United Kingdom. Steering Committee for the UK-External Quality Assessment Scheme for Therapeutic Drug Assays.
    Burnett D; Lader S; Richens A; Smith BL; Toseland PA; Walker G; Williams J; Wilson JF
    Ann Clin Biochem; 1990 May; 27 ( Pt 3)():213-22. PubMed ID: 2382955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of detection techniques and laboratory proficiency in testing for drugs of abuse in urine: an external quality assessment scheme using clinically realistic urine samples. Steering Committee for the United Kingdom National External Quality Assessment Scheme for Drugs of Abuse in Urine.
    Wilson JF; Smith BL
    Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():592-600. PubMed ID: 10505208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HAIRVEQ 2006: evolution of laboratories' performance after different educational actions.
    Ventura M; Stramesi C; Pichini S; Ventura R; Pujadas M; Di Giovannandrea R; Zuccaro P; Pacifici R; Langohr K; de la Torre R
    Forensic Sci Int; 2008 Mar; 176(1):2-8. PubMed ID: 17980986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HAIRVEQ: an external quality control scheme for drugs of abuse analysis in hair.
    Pichini S; Ventura M; Pujadas M; Ventura R; Pellegrini M; Zuccaro P; Pacifici R; de la Torre R
    Forensic Sci Int; 2004 Oct; 145(2-3):109-15. PubMed ID: 15451081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Workplace drug testing in Italy: findings about second-stage testing.
    Vignali C; Stramesi C; Morini L; San Bartolomeo P; Groppi A
    Drug Test Anal; 2015 Mar; 7(3):173-7. PubMed ID: 24652693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ORALVEQ: external quality assessment scheme of drugs of abuse in oral fluid: results obtained in the first round performed in 2007.
    Ventura M; Ventura R; Pichini S; Leal S; Zuccaro P; Pacifici R; Langohr K; de la Torre R
    Forensic Sci Int; 2008 Nov; 182(1-3):35-40. PubMed ID: 19004584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient performance of drugs of abuse testing in Sweden: an external control study.
    Lafolie P; Beck O
    Scand J Clin Lab Invest; 1994 May; 54(3):251-6. PubMed ID: 8036451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for drugs of abuse (II): Cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs.
    Simpson D; Braithwaite RA; Jarvie DR; Stewart MJ; Walker S; Watson IW; Widdop B
    Ann Clin Biochem; 1997 Sep; 34 ( Pt 5)():460-510. PubMed ID: 9293303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proficiency testing (external quality assessment) of drug detection in oral fluid.
    Clarke J; Wilson JF
    Forensic Sci Int; 2005 Jun; 150(2-3):161-4. PubMed ID: 15944056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey on drugs-of-abuse testing in the European Union.
    Badia R; Segura J; Artola A; de la Torre R
    J Anal Toxicol; 1998; 22(2):117-26. PubMed ID: 9547408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Workplace drug testing in Italy - critical considerations.
    Vignali C; Stramesi C; Morini L; Pozzi F; Collo G; Groppi A
    Drug Test Anal; 2013 Apr; 5(4):208-12. PubMed ID: 23355251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NPS-EQA PART I: Four years' experience in external quality assessment program in Italy for classical and new psychoactive substances analysis in oral fluid.
    Marchei E; Graziano S; Varì MR; Minutillo A; Aquilina V; Pichini S; Rotolo MC
    J Pharm Biomed Anal; 2024 Jun; 243():116084. PubMed ID: 38452420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory and clinical evaluation of on-site urine drug testing.
    Beck O; Carlsson S; Tusic M; Olsson R; Franzen L; Hulten P
    Scand J Clin Lab Invest; 2014 Nov; 74(8):681-6. PubMed ID: 25046332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.